- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2018
- Public Summary Document (PSD) March 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2018 PBAC Meeting - Word
Pegfilgrastim – March 2018
Pegfilgrastim: Injection 6 mg in 0.6 mL, single use pre-filled syringe; Neulasta®
Last updated
29 June 2018